Menu
Not yet recruiting NCT07612397

Effects of Jaw Clenching on Gait and Mobility in Stroke

No phase Interventional Stroke

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Voluntary Jaw Clenching, Sham Cotton Roll Placement Without Clenching.
Who it may be relevant to
Registry conditions: Stroke. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Immediate Effects of Jaw Clenching on Gait and Functional Mobility in Patients With Chronic Stroke

Overview

The aim of this study is to investigate the immediate effects of jaw clenching on gait and functional mobility in patients with chronic stroke.

Detailed description

This randomized sham-controlled crossover study aims to investigate the immediate effects of jaw clenching on gait and functional mobility in patients with chronic stroke. A minimum of 30 eligible patients will be included. Each participant will complete both the intervention and sham conditions in a randomized sequence.

Interventions

  • Other Voluntary Jaw Clenching
    In this group, 1-cm-thick cotton rolls will be placed bilaterally on the occlusal surfaces, and patients will be instructed to perform maximal voluntary tooth clenching.
  • Other Sham Cotton Roll Placement Without Clenching
    In this group, 1-cm-thick cotton rolls will be placed bilaterally on the occlusal surfaces without any clenching instruction, and participants will be instructed to keep their jaw relaxed.

Primary outcome measures

  • Timed Up and Go (TUG) Test [Time frame: Baseline and immediately post-intervention for both experimental and sham conditions]
  • 10-Meter Walk Test (10MWT) [Time frame: Baseline and immediately post-intervention for both experimental and sham conditions]

Eligibility criteria

Inclusion criteria

  • Stroke occurred at least 6 months prior to enrollment.
  • No cognitive or communication impairments that would interfere with participation.
  • Ability to stand independently for 20 seconds or more.
  • Ability to walk 10 meters independently, with or without walking aids or orthoses as needed.
  • Age between 18 and 75 years.
  • Lower extremity Brunnstrom stage of 4 or higher.

Exclusion criteria

  • Presence of severe osteoarthritis in the lower extremities.
  • Diagnosis of cancer or diabetic neuropathy.
  • Presence of vestibular disorders.
  • Lower extremity ulceration or amputation.
  • History of vertigo.
  • Alcohol consumption within the past 24 hours.
  • Hemodynamic instability.
  • Stroke affecting the basilar artery or cerebellum (posterior circulation stroke).
  • Presence of neurological disorders such as multiple sclerosis or Parkinson's disease.
  • Acute lower extremity injury within the past 6 weeks.
  • History of lower extremity surgery.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Bolu İzzet Baysal Fizik Tedavi ve Rehabilitasyon Eğitim ve Araştırma Hastanesi — Bolu

Identifiers

NCT: NCT07612397 · Beuftr_3

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗